TME Pharma NV (ALTME)

Currency in EUR
0.0777
+0.0038(+5.14%)
Closed·
ALTME is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.07400.0777
52 wk Range
0.04900.1480
Key Statistics
Prev. Close
0.0739
Open
0.075
Day's Range
0.074-0.0777
52 wk Range
0.049-0.148
Volume
81.26K
Average Volume (3m)
430.34K
1-Year Change
11.9697%
Book Value / Share
-0.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALTME Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

TME Pharma NV News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

TME Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. The company’s Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, and glioblastoma. It also developing NOX-E36, which has completed Phase 1/2a clinical trial for the treatment of diabetic nephropathy. The company was formerly known as NOXXON Pharma N.V. and changed its name to TME Pharma N.V. in July 2022. TME Pharma N.V. was founded in 1997 and is headquartered in Berlin, Germany.

Compare ALTME to Peers and Sector

Metrics to compare
ALTME
Peers
Sector
Relationship
P/E Ratio
−1.5x6.6x−0.4x
PEG Ratio
−0.02−0.070.00
Price/Book
−12.2x2.0x2.6x
Price / LTM Sales
257.5x2.3x3.2x
Upside (Analyst Target)
-34.8%46.7%
Fair Value Upside
Unlock7.0%7.6%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Oct 30, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
27K / --
EPS Revisions
Last 90 days

ALTME Income Statement

People Also Watch

0.3785
ALSEN
-1.30%
40.54
AL2SI
-1.79%
1.010
ALVAL
+1.00%
3.580
ALTHX
+6.71%
1.0320
ALGID
-19.38%

FAQ

What Is the TME Pharma NV (ALTME) Stock Price Today?

The TME Pharma NV stock price today is 0.0777 EUR.

What Stock Exchange Does TME Pharma NV Trade On?

TME Pharma NV is listed and trades on the Paris Stock Exchange.

What Is the Stock Symbol for TME Pharma NV?

The stock symbol for TME Pharma NV is "ALTME."

What Is the TME Pharma NV Market Cap?

As of today, TME Pharma NV market cap is 7.3100M EUR.

What Is TME Pharma NV's Earnings Per Share (TTM)?

The TME Pharma NV EPS (TTM) is -0.0660.

From a Technical Analysis Perspective, Is ALTME a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has TME Pharma NV Stock Split?

TME Pharma NV has split 1 times.

How Many Employees Does TME Pharma NV Have?

TME Pharma NV has 12 employees.

What is the current trading status of TME Pharma NV (ALTME)?

As of Apr 24, 2026, TME Pharma NV (ALTME) is trading at a price of 0.0777 EUR, with a previous close of 0.0739 EUR. The stock has fluctuated within a day range of 0.0740 EUR to 0.0777 EUR, while its 52-week range spans from 0.0490 EUR to 0.1480 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.